R S Kotecha
Overview
Explore the profile of R S Kotecha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stutterheim J, de Lorenzo P, van der Sluis I, Alten J, Ancliffe P, Attarbaschi A, et al.
Eur J Cancer
. 2021 Nov;
160:72-79.
PMID: 34785111
Background: The outcome of infants with KMT2A-germline acute lymphoblastic leukaemia (ALL) is superior to that of infants with KMT2A-rearranged ALL but has been inferior to non-infant ALL patients. Here, we...
2.
Mateos M, Trahair T, Mayoh C, Barbaro P, Sutton R, Revesz T, et al.
Thromb Res
. 2019 Apr;
178:132-138.
PMID: 31030032
Background: Symptomatic venous thromboembolism (VTE) is an unpredictable and life-threatening toxicity, which occurs early in childhood acute lymphoblastic leukemia (ALL) therapy. Approximately 5% of children will experience VTE which is...
3.
Cruickshank M, Ford J, Cheung L, Heng J, Singh S, Wells J, et al.
Leukemia
. 2016 Jul;
31(1):40-50.
PMID: 27443263
To address the poor prognosis of mixed lineage leukemia (MLL)-rearranged infant acute lymphoblastic leukemia (iALL), we generated a panel of cell lines from primary patient samples and investigated cytotoxic responses...
4.
Kotecha R, Gottardo N, Kees U, Cole C
Blood Cancer J
. 2014 Apr;
4:e200.
PMID: 24727996
Acute lymphoblastic leukemia (ALL) in infants has a significantly inferior outcome in comparison with older children. Despite initial improvements in survival of infants with ALL since establishment of the first...